Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Non-small Cell Carcinoma × Pemetrexed × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 125 Lung Neoplasms 27 Carcinoma 10 Parkinson Disease 4, Autosomal Dominant Lewy Body 9 Neoplasms 8 Neoplasm Metastasis 8 Mesothelioma 5 Uterine Cervical Neoplasms 4 Mesothelioma, Malignant 4 Thoracic Neoplasms 3 Respiratory Tract Neoplasms 3 Respiratory Tract Diseases 3 Non-squamous Non-small Cell Lung Cancer 3 Non-Squamous Non-Small Cell Lung Cancer 3 Neoplasms by Site 3 NSCLC 3 Lung Diseases 3 Carcinoma, Bronchogenic 3 Adenocarcinoma of Lung 3 Adenocarcinoma 3 Recurrence 2 Non-Squamous Non-small Cell Lung Cancer 2 Head and Neck Neoplasms 2 Bronchial Neoplasms 2 Brain Neoplasms 2 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer 1

Interventions

osimertinib 1 Pemetrexed 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04695925 2025-10-15

TOP

Sun Yat-sen University

Phase 3 Active not recruiting

Non-small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡